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Abstract
Introduction: A history of an adverse reaction to amoxicillin, irrespective of the mechanism involved, significantly elevates pa-
tients’ anxiety and affects therapeutic decisions in the future, leading to unnecessary avoidance of antibiotics. As a consequence, 
it would be useful to find a safe and reliable protocol for typing safe alternative antibiotics.
The aim of the study was to determine negative predictive value of typing safe antibiotic in patients with a history of hypersen-
sitivity reaction to amoxicillin. 
Material and methods: 71 patients, aged 20−83, with a history of an adverse reaction to amoxicillin were retrospectively 
analysed. On the basis of the reaction type they were divided into three groups: A — symptoms not typical for hypersensitivity 
reactions, B — allergy manifested by urticaria and/or angioedema, C — anaphylaxis. In group A amoxicillin was tested, in group 
B — cefuroxime, and in group C — macrolide: azithromycin or clarithromycin. Telephone follow-up visits were performed twice: 
6−12 months and 3−5 years after the clinical assessment to evaluate tolerance of antibiotics. On the basis of the follow-up 
results, the negative predictive value (NPV) of the protocol was calculated.
Results: The full diagnostic protocol was applied in 62 participants. Amoxicillin was found safe in 22, cefuroxime — in 21 and 
macrolide — in 19 patients. No anaphylactic reactions were observed during the tests. On the basis of the telephone follow-up, 
the NPV of the protocol was 96% in the first follow-up and 97% in the second one.
Conclusion: A stepwise approach including SPTs, ICTs and provocations with amoxicillin / cefuroxime/macrolide — depending 
on a patient’s history — is safe and allows typing an antibiotic in the vast majority of patients.
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Introduction
Beta-lactams are widely used antibiotics, 
particularly in the therapy of respiratory and 
urinary tract infections. According to both Po-
lish and international guidelines, amoxicillin, 
either alone or combined with clavulate, is the 
first-choice antibiotic in therapy of pneumonia, 
sinusitis, otitis media and other common bacte-
rial infections [1, 2]. Although beta-lactams are 
generally considered safe, patients often report 
adverse reactions to them [3, 4]. 
Adverse drug reactions can be classified into 
two major types: A — grouping those dose-depen-
dent and predictable, and B — not dose-dependent 
and unpredictable. In relation to beta-lactams, 
type A reactions include, e.g. diarrhoea, pseudo-
membranous colitis or candidosis resulting from 
a change in the bacterial flora. On the contrary, 
allergy is a type B, immune reaction observed only 
in a group of sensitized individuals.
A history of an adverse reaction to an an-
tibiotic, irrespective of a mechanism involved, 
significantly elevates patients’ anxiety and affects 
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therapeutic decisions in the future. In some cases, 
the whole group of beta-lactams is advised to be 
avoided or a decision to start therapy is delayed. 
As a consequence, it seems necessary to find a safe 
and reliable protocol for typing safe antibiotics for 
patients with history of hypersensitivity reaction 
related to amoxicillin. In the literature several 
such protocols have been described which aim at 
confirming hypersensitivity [5, 6]. Most of them 
were based on skin tests and drug provocation 
tests (DPT). However, little is known about their 
negative predictive value in ‘real life’ conditions.
The aim of the study was to determine nega-
tive predictive value for typing safe antibiotics in 
patients with a history of allergy to amoxicillin. 
Material and methods
71 patients, including 68 women and 3 men, 
with a history of an adverse reaction to amoxicil-
lin were retrospectively analysed. The mean age 
at the time of drug typing was 53 years (range 
20−82 years). The participants were hospitalized 
at the Department of Allergology, Medical Uni-
versity of Gdańsk from January 2010 to December 
2012. Exclusion criteria included: pregnancy, 
acute infection, beta-blockers intake, unstable 
circulatory insufficiency and any other situation 
that could, in our opinion, affect the patients’ 
safety or reliability of the tests. Before inclusion, 
the patients gave written informed consent for all 
the procedures.
On the basis of the history of the reaction 
to amoxicillin patients were divided into three 
groups: A — symptoms not typical for hypersen-
sitivity reactions (diarrhoea, heart palpitations, 
malaise, etc.), B — allergy manifested by urticaria 
and/or angioedema, C — anaphylaxis — as defi-
ned by Sampson et al. [7] (Fig. 1). Our diagnostic 
approach varied between the groups. In group A, 
amoxicillin was tested as the probability of true al-
lergy was considered low. In patients from group B, 
allergy was assessed to be probable, but there was 
no history of anaphylaxis. Thus, they were tested 
with cefuroxime. Finally, group C, with a history of 
anaphylaxis related to amoxicillin, was provoked 
with macrolide (azithromycin or clarithromycin). 
Before drug typing medications that could af-
fect the results of the tests were withdrawn accor-
ding to general guidelines [8]. A stepwise typing 
of a safe beta-lactam (amoxicillin, cefuroxime) 
included skin prick tests (SPT), intracutaneous 
tests (ICT) and oral drug provocation tests (DPT). 
The positive control was a prick test with hista-
mine and negative — with saline. In SPTs and 
ICTs, the drugs’ concentrations applied were 20 
mg/ml for amoxicillin and 2 mg/ml for cefuroxi-
me. Skin prick tests were considered positive if 
a wheal of 3 mm or more in diameter was found. 
Intracutaneous tests were assessed as positive 
in case of a wheal of 5 mm in diameter or more 
with erythema. Skin tests were followed by oral, 
single-blind, placebo-controlled drug provocation 
tests. Doses were administered every 60 minutes 
(10, 90, 150, 250, 500 mg of amoxicillin or 5, 95, 
150, 250 mg of cefuroxime). 
Typing of a macrolide (clarithromycin or 
azithromycin) included single-blind, placebo-con-
trolled oral provocation tests with increasing doses 
of the drug: 5, 95, 150, 250 mg (every 60 minutes).
In all the protocols, if one of the steps yiel-
ded a reaction, the drug was excluded from fur-
SPT — skin prick test; ICT — intracutaneous test; DCT — drug challenge test
Figure 1. Algorithm of choosing antibiotic for typing
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Table 1. Results of skin prick tests (SPT), intracutaneous tests (ICT) and drug provocation tests (DPT) with amoxicillin, 
cefuroxime and macrolides
Number of SPT 
with the drug 
SPT 
Number of po-
sitive results
Number of ICT 
with the drug
ICT
Number of po-
sitive results
Number of pro-
vocation tests 
with the drug
DPT
Number of po-
sitive results
Amoxicillin
(group A)
23 0 23 0 23 1
Cefuroxime
Group B
Group C
22
3
1
0
21
3
2
0
19
3
1
0
Clarithromycin/
azithromycin
Group A
Group B
Group C
N/A N/A N/A N/A
1
4
17
0
0
3
ther tests. In cases of hypersensitivity reaction, 
provocation was ceased and, after 24 hours free 
from symptoms, another antibiotic was tested 
(macrolide — in cases of reaction to beta-lactam 
and vice versa). 
Telephone follow-up visits were performed 
6−12 months and 3−5 years after drug typing. 
Patients were asked questions about antibiotics 
used since the visit in the clinic and adverse 
reactions related to their administration. On 
the basis of the follow-up results, negative pre-
dictive value (NPV) of the typing protocol was 
calculated.
Results
71 patients were admitted to the Department 
of Allergology for typing of a safe antibiotic. 39 
of them had a history of immediate hypersensiti-
vity reaction after administration of amoxicillin 
and 32 — amoxicillin with clavulate. Patients 
reported: urticaria — 34 cases, angioedema — 
24, skin redness — 20, shortness of breath — 19, 
abdominal pain — 16, nausea — 14, diarrhoea 
— 8, vomiting — 4, loss of consciousness — 8, 
dizziness — 6, malaise — 26. As a consequence, 
28 patients were assigned to group A, 25 — gro-
up B and 18 — group C. 15 patients reported 
reactions to other antibiotics as well, mostly to 
macrolides (9 patients) followed by clindamycin 
(2 patients), doxycycline (2 patients), sulfame-
thoxazole+trimethoprim (2 patients) and cipro-
floxacin (1 patient). 
During the tests one patient withdrew infor-
med consent and eight reacted to placebo. Thus, 
only in 62 participants (group A — 23, B — 22, 
C — 17) full protocol was performed and this 
group was included into analysis.
The results of skin tests and provocations 
with antibiotics are presented in Table 1. In gro-
up A, most of the participants had negative skin 
tests and provocation tests with amoxicillin. One 
patient developed urticaria during provocation 
with amoxicillin and a macrolide was found safe 
for him. In group B, 18 participants tolerated 
cefuroxime, in 3 cases positive results of skin 
test were found and in 1 case — provocation test 
was positive. In all the positive responders ma-
crolide was found safe. In group C, 14 patients 
have not had any symptoms of hypersensitivity 
to macrolide. In 3 positive responders cefuroxime 
was found safe. 
Finally, in all participants who did not re-
spond to placebo it was possible to type a safe 
antibiotic. Amoxicillin was found safe in 22 
cases, cefuroxime — in 21 and macrolide — in 
19 patients.
The results of a telephone follow-up are 
presented in Table 2. After 6−12 months it was 
possible to contact 50 (80%) participants. A 
drug typed at a clinical visit was administered 
in 28 patients and 25 reported no reactions. Two 
patients reported diarrhoea and abdominal pain 
they experienced after 4−5 days of the therapy 
with amoxicillin. The symptoms resolved spon-
taneously and were not accompanied by any ty-
pical symptom of hypersensitivity reaction. One 
patient had delayed skin reaction (papular rash 
with itching) after 3-day therapy with azithromy-
cin. As we did not consider isolated diarrhoea an 
allergic reaction, the negative predictive value of 
the protocol applied in the study was 96%. After 
3−5 years 53 patients (85%) were contacted and 
29 tolerated antibiotic typed in the clinic. No new 
reactions were reported. As a consequence NPV 
of the protocol was 97%.
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Table 2. Patients’ answers on the telephone follow-up
Patients’ answers on follow-up call Number of patients (%)
6−12 months after
work-up
3−5 years after 
work-up
Antibiotic typed in the clinic was administered and no reaction occurred
Antibiotic typed in the clinic was administered and reaction occurred
Antibiotic was administered but patient does not know its name; no reaction occurred
Antibiotic was administered but patient does not know its name; reaction occurred
No antibiotics were administered because there were no indications for them
No antibiotics were administered because I was still afraid of them
No antibiotics were administered because my doctor tried to avoid them in spite of typing a 
safe antibiotic
25 (50%)
3 (6%)
3 (6%)
0 (0%)
15 (30%)
3 (6%)
1 (2%)
29 (55%)
3 (6%)
4 (7%)
0 (0%)
12 (23%)
4 (7%)
1 (2%)
Discussion 
 IgE-mediated reactions to antibiotics are 
usually characterized by urticaria, angioede-
ma, itching, shortness of breath, wheezing and 
a drop in blood pressure. Symptoms develop 
immediately, most often within 1 hour of drug 
intake, and may be life-threatening. However the 
vast majority of adverse reactions to antibiotics 
are non-immunologic and their clinical manife-
station is usually mild. Nevertheless, they often 
raise confusion among doctors and make patients 
anxious. In many cases the term “allergy” is ap-
plied in an uncritical fashion to all the possible 
reactions and, as a consequence, penicillins and 
cephalosporins are unnecessarily avoided. Thus, 
it is necessary to find safe and reliable protocols 
of finding antibiotics for future therapy in the 
extremely heterogenous group of patients with 
histories of wide spectrum of reactions — from 
severe anaphylaxis to mild, non-allergic adverse 
reactions.
The typing of a drug for use in an undefined 
future was quite controversial. In the 1980s, it 
was believed that the results of testing should not 
be used for more than 72 hours because even the 
patients with negative skin tests could be sensiti-
zed after environmental exposure, and the course 
of their allergy was unpredictable [9]. However, 
in the following years it was demonstrated that 
sensitization to penicillins is not common. In 
the study of Lopez-Serrano and co-workers, 207 
patients with negative penicillin skin tests and 
challenges had a repeated work-up after 10−30 
days and conversion to positive skin tests was ob-
served only in 5 subjects [10]. Solensky included 
into his study 46 patients with a positive history 
of allergy and negative skin tests. They were given 
a 10-day course of oral penicillin with repeated 
skin tests that were all negative [11]. Finally, 
in the study of Macy et al., 568 patients with a 
history of an adverse reaction and negative skin 
tests with penicillin were followed-up over about 
4 years and 88.6% did not react to oral penicillin 
during the observation [12].
We included into this study a varied group 
of patients who were referred to our clinic with 
the suspicion of an allergy to amoxicillin which 
is now the most commonly used beta-lactam in 
Poland. In the traditional approach the emphasis 
is usually put on confirming the suspicion of al-
lergy with the use of skin tests, in vitro tests and 
provocations [6]. As a consequence, patients are 
provided with information on “forbidden” anti-
biotics but they are still very anxious about using 
an alternative drug. Thus, we aimed at assessing 
a protocol for typing an antibiotic for a future 
therapy. We divided our subjects into three groups 
on the basis of the history of the reaction. Amoxi-
cillin was tested in group A (patients with a low 
risk of true allergy) — where vast majority showed 
negative results. The work-up ensured them that 
the reported symptoms had not resulted from a 
drug allergy and amoxicillin can be administered 
safely if necessary. In patients with a history of 
urticaria/angioedema (group B), cefuroxime was 
tested. We decided to use cefuroxime because it 
may be used in numerous clinical situations and 
is available in both oral and intravenous forms. 
Cross-reactivity between penicillins and cepha-
losporins has been shown and often results from 
similarities in the structure of side chains from 
similarities in the structure of side chains [13]. 
However, cross-reactions are now observed less 
often than previously described which may be 
partly explained by the fact that early cephalo-
sporin antibiotics contained traces of penicillin 
[14, 15]. In the study of Macy et al. in penicillin 
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skin test positive individuals, the adverse drug 
reaction rate was similar with cephalosporin and 
non-beta-lactam use [16]. In our study, 18 out of 
22 patients from group B tolerated cefuroxime. 
Finally, 17 patients with amoxicillin-induced 
anaphylaxis were provoked with macrolide and 
14 had no reaction.
In the present study we evaluated the NPV of 
the protocol based on SPT, ICT and DPT. When 
typing beta-lactams (amoxicillin and cefuroxime) 
we started with SPT and ICT. In cases with nega-
tive results we proceeded to DPT, as described by 
other authors [17]. In protocols used in Western 
Europe skin tests with penicylloil polylysine 
(PPL) and minor determinants mixture (MDM) 
are routinely performed at the same time [6]. 
However, in Poland major and minor penicillin 
determinants are not available, so we were not 
able to follow this protocol. Also, we have not 
determined sIgE against penicillins and cephalo-
sporins, which resulted from the low sensitivity 
of this test [18]. In case of macrolides, skin tests 
are generally considered unreliable, so the typing 
included provocation testing only [19, 20]. 
The protocol applied in this study was very 
safe as we had no anaphylactic reactions, and the 
positive responses during DPTs were mostly limited 
to skin reactions. We found a low number of positive 
results in both skin tests and DPTs probably due 
to the fact that the culprit drug was tested only in 
group A, with the history of not being so indica-
tive of true allergy. The comparison of sensitivity 
and specificity of skin tests and drug challenges 
was not possible as for provocations we only had 
selected substances that did not yield reactions in 
SPT and ICT. 
The follow-up telephone visits were success-
ful in 53 (85%) participants. Among the patients 
we contacted, 4 tried to avoid the therapy with 
an antibiotic even despite the clear indication for 
using it and 1 was not prescribed antibiotic by a 
family doctor who claimed that there is still some 
risk in taking it. That might reflect the high level 
of stress and anxiety resulting from the history of 
anaphylaxis. 32 participants were given a typed 
antibiotic, most of them because of respiratory 
tract infections. In the vast majority of cases no 
allergic reactions were observed. Our result is in 
line with the multicentre study of P. Demoly et 
al. [6]. It included 456 patients who were chal-
lenged with several beta-lactams, depending on 
the history of hypersensitivity. In the follow-up, 
109 out of 118 participants reported no allergic 
reaction to the tested antibiotic, so the NPV was 
94%. Although this protocol differed from the 
one used in our study, both of them showed a 
high value of stepwise typing of a safe antibiotic.
Our study has assessed the typing of an-
tibiotics in ‘real life’ settings where patients’ 
safety is the priority. Nevertheless, it has some 
limitations. The most important one is the fact 
that we have not confirmed allergy to amoxicillin 
in patients with a history of amoxicillin-induced 
anaphylaxis. They were left with the suspicion 
of an allergy for the rest of their lives. On the 
other hand severe anaphylaxis is regarded as 
contraindication for provocation tests in most 
guidelines, including ENDA recommendations 
[8]. Another limitation is the lack of tests with 
clavulate. Although isolated hypersensitivity to 
clavulate has been described and a part of our 
group had a history of a reaction to amoxicillin 
with clavulate, it is not available in the form of 
a solution for skin testing and provocations [21]. 
We also shared problems that are common in 
most of the studies on the allergy to antibiotics. 
They are a rather rarely used group of drugs, so in 
the follow-up many patients cannot assess their 
safety. In our study, 23% of participants did not 
use any antibiotics during the follow-up period 
because they were not necessary. That reduced 
the number of answers on tolerability of the drug 
typed, but our proportion is still low compared 
to other studies [6]. The question of how long 
the results are predictive is still current, but the 
majority of patients seem to tolerate the tested 
antibiotics for a long period of time. Finally, what 
makes diagnosing of drug allergy very compli-
cated is the influence of cofactors such as viral 
infection, physical exercise or alcohol. Their role 
was not assessed in our group. 
Conclusion
The stepwise approach including skin prick 
tests, intracutaneous tests and provocations with 
amoxicillin, cefuroxime and clarithromycin is a 
safe procedure and allows typing an antibiotic 
for the use in real life clinical situations in a vast 
majority of patients.
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